跳至主要内容
临床试验/EUCTR2012-002572-13-DK
EUCTR2012-002572-13-DK进行中(未招募)不适用

Efficacy of midodrine for the prevention of orthostatic hypotension during early mobilization after fast-track hip arthroplasty - a randomized, placebo controlled trial

Henrik Kehlet0 个研究点开始时间: 2012年7月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Scheduled for primary unilateral hip arhtroplasty in one of the participating centers
  • -Age >= 18 years
  • -Able to give informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 80

排除标准

  • - General anaesthesia for the current procedure
  • - Digoxin treatment.
  • - history of renal or hepatic failure
  • - history of glaucoma
  • - history chronic urinary retention requiring treatment
  • - history of orthostatic intolerance / hypotension
  • - other autonomous nervous system disease
  • - alcohol or drug abuse
  • - current malignant disease
  • - females in the fertile age (possible pregnancy or breast feeding)
  • - Treatment with anticoagulants
  • - BMI > 40 kg/m2
  • - Dementia or cognitive dysfunction (investigators evaluation)

研究者

发起方
Henrik Kehlet

相似试验